MetaCap

National Vision Financial Ratios

NASDAQ: EYEHealth CareOphthalmic GoodsUSD

16.68-0.06 (-0.36%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

National Vision ratio analysis

National Vision earned a net margin of 1.5% in FY 2025, up from -1.6% a year earlier. Gross margin was 58.8% compared with a median of 54.5% over the prior 9 years. Return on equity reached 3.4%, meaning National Vision generated 0.03 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.27 versus 0.41 the year before, and the current ratio was 0.55. At the end of FY 2025, EYE traded at 70.1 times earnings; across the 7 fiscal years shown, its year-end P/E ranged from 33.6 to 102.9, with a median of 74.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

National Vision financial ratios (annual)

National Vision annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)70.14——74.5433.56102.9382.7596.6058.01—
Price / sales1.030.460.931.881.892.131.511.431.77—
Price / book2.361.021.983.434.244.033.352.963.72—
Gross margin58.8%58.1%58.2%59.4%56.5%54.0%53.2%53.6%53.7%54.5%
Operating margin3.0%-0.6%1.4%3.2%8.4%5.1%4.3%2.8%4.7%5.4%
Net margin1.5%-1.6%-3.8%2.6%6.2%2.1%1.9%1.5%3.1%1.1%
Free cash flow margin3.7%2.1%3.3%0.3%7.9%9.2%3.7%0.1%-0.2%0.6%
Return on equity (ROE)3.4%-3.5%-7.9%4.7%13.8%4.0%4.2%3.2%6.6%3.3%
Return on assets (ROA)1.5%-1.4%-3.0%1.8%5.6%1.6%1.6%1.4%2.7%0.9%
Debt / equity0.270.410.540.610.590.690.690.780.871.87
Current ratio0.550.531.001.381.501.720.861.010.770.74
Revenue growth9.0%3.8%6.8%-20.9%21.5%-0.7%12.2%11.7%15.0%12.6%
EPS growth——-261.5%-63.6%225.0%10.0%33.3%-57.1%204.3%283.3%

Related